Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16682145 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)
Condition: Non-Small Cell Lung Cancer
Interventions: Radiation: PET positive nodal disease measuring 15 mm or greater;   Radiation: PET positive nodal disease measuring less than 15 mm;   Radiation: Patients considered resectable

Indicates status has not been verified in more than two years